E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Gro... von Connolly, Roisin M., Zhao, Fengmin, Miller, Kathy D., Lee, Min-Jung, Piekarz, Richard L., Smith, Karen L., Brown-Glaberman, Ursa A., Winn, Jennifer S., Faller, Bryan A., Onitilo, Adedayo A., Burkard, Mark E., Budd, George T., Levine, Ellis G., Royce, Melanie E., Kaufman, Peter A., Thomas, Alexandra, Trepel, Jane B., Wolff, Antonio C., Sparano, Joseph A.

Volltext

NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer von Ademuyiwa, Foluso O, Bshara, Wiam, Attwood, Kristopher, Morrison, Carl, Edge, Stephen B, Karpf, Adam R, James, Smith A, Ambrosone, Christine B, O'Connor, Tracey L, Levine, Ellis G, Miliotto, Anthony, Ritter, Erika, Ritter, Gerd, Gnjatic, Sacha, Odunsi, Kunle

Volltext

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial von Soliman, Hatem, Shah, Varsha, Srkalovic, Gordan, Mahtani, Reshma, Levine, Ellis, Mavromatis, Blanche, Srinivasiah, Jayanthi, Kassar, Mohamad, Gabordi, Robert, Qamar, Rubina, Untch, Sarah, Kling, Heather M., Treece, Tina, Audeh, William

Volltext

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience von Alaklabi, Sabah, Roy, Arya Mariam, Attwood, Kristopher, George, Anthony, O'Connor, Tracey, Early, Amy, Levine, Ellis G, Gandhi, Shipra

Volltext

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial von Albain, Kathy S, Prof, Barlow, William E, Prof, Ravdin, Peter M, Prof, Farrar, William B, Prof, Burton, Gary V, Prof, Ketchel, Steven J, MD, Cobau, Charles D, MD, Levine, Ellis G, MD, Ingle, James N, Prof, Pritchard, Kathleen I, Prof, Lichter, Allen S, Prof, Schneider, Daniel J, MD, Abeloff, Martin D, Prof, Henderson, I Craig, Prof, Muss, Hyman B, Prof, Green, Stephanie J, Prof, Lew, Danika, MA, Livingston, Robert B, Prof, Martino, Silvana, DO, Osborne, C Kent, Prof

Volltext

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216) von Agarwal, Neeraj, Tangen, Catherine M, Hussain, Maha H A, Gupta, Shilpa, Plets, Melissa, Lara, Primo N, Harzstark, Andrea L, Twardowski, Przemyslaw W, Paller, Channing J, Zylla, Dylan, Zibelman, Matthew R, Levine, Ellis, Roth, Bruce J, Goldkorn, Amir, Vaena, Daniel A, Kohli, Manish, Crispino, Tony, Vogelzang, Nicholas J, Thompson, Jr, Ian M, Quinn, David I

Volltext

Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer von HALABI, Susan, SMALL, Eric J, KANTOFF, Philip W, KATTAN, Michael W, KAPLAN, Ellen B, DAWSON, Nancy A, LEVINE, Ellis G, BLUMENSTEIN, Brent A, VOGELZANG, Nicholas J

Volltext

Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study von Abraham, Adith, Barcenas, Carlos H., Bleicher, Richard J., Cohen, Adam L., Javid, Sara H., Levine, Ellis G., Lin, Nancy U., Moy, Beverly, Niland, Joyce C., Wolff, Antonio C., Hassett, Michael J., Asad, Sarah, Stover, Daniel G.

Volltext

Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study von Sarma, Maithreyi, Perimbeti, Stuthi, Nasir, Samar, Attwood, Kristopher, Kapoor, Ankita, O’Connor, Tracey, Early, Amy, Levine, Ellis G., Takabe, Kazuaki, Kalinski, Pawel, Ambrosone, Christine, Khoury, Thaer, Yao, Song, Gandhi, Shipra

Volltext

Impact of suboptimal neoadjuvant chemotherapy on peri‐operative outcomes and survival after robot‐assisted radical cystectomy: a multicentre multinational study von Hinata, Nobuyuki, Hussein, Ahmed Aly, George, Saby, Trump, Donald L., Levine, Ellis G., Omar, Kawa, Dasgupta, Prokar, Khan, Muhammad Shamim, Hosseini, Abolfazl, Wiklund, Peter, Guru, Khurshid A.

Volltext

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103 von Ujjani, Chaitra S., Jung, Sin-Ho, Pitcher, Brandelyn, Martin, Peter, Park, Steven I., Blum, Kristie A., Smith, Sonali M., Czuczman, Myron, Davids, Matthew S., Levine, Ellis, Lewis, Lionel D., Smith, Scott E., Bartlett, Nancy L., Leonard, John P., Cheson, Bruce D.

Volltext

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx von Gandhi, Shipra, Opyrchal, Mateusz, Grimm, Melissa J, Slomba, Ronald T, Kokolus, Kathleen M, Witkiewicz, Agnieszka, Attwood, Kristopher, Groman, Adrienne, Williams, Lauren, Tarquini, Mary Lynne, Wallace, Paul K, Soh, Kah Teong, Minderman, Hans, Maguire, Orla, O’Connor, Tracey L, Early, Amy P, Levine, Ellis G, Kalinski, Pawel

Volltext

Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib von Dhakal, Ajay, Antony Thomas, Roby, Levine, Ellis G, Brufsky, Adam, Takabe, Kazuaki, Hanna, Matthew G, Attwood, Kristopher, Miller, Austin, Khoury, Thaer, Early, Amy P, Soniwala, Saif, O’Connor, Tracy, Opyrchal, Mateusz

Volltext

Determinants of response to CDK4/6 inhibitors in the real-world setting von Witkiewicz, Agnieszka K., Schultz, Emily, Wang, Jianxin, Hamilton, Deanna, Levine, Ellis, O’Connor, Tracey, Knudsen, Erik S.

Volltext

Barriers to Clinical Trial Participation by Older Women With Breast Cancer von KEMENY, M. Margaret, PETERSON, Bercedis L, KORNBLITH, Alice B, MUSS, Hyman B, WHEELER, Judith, LEVINE, Ellis, BARTLETT, Nancy, FLEMING, Gini, COHEN, Harvey J

Volltext

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin von Lang, Jennifer K, Karthikeyan, Badri, Quiñones-Lombraña, Adolfo, Blair, Rachael Hageman, Early, Amy P, Levine, Ellis G, Sharma, Umesh C, Blanco, Javier G, O'Connor, Tracey

Volltext

Understanding Avoidance, Refusal, and Abandonment of Chemotherapy Before and After Cystectomy for Bladder Cancer von Rehman, Shabnam, Crane, Alice, Din, Rakeeba, Raza, Syed Johar, Shi, Yi, Wilding, Gregory, Levine, Ellis G, George, Saby, Pili, Roberto, Trump, Donald L, Guru, Khurshid A

Volltext

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN) von Ademuyiwa, Foluso O., Northfelt, Donald W., O’Connor, Tracey, Levine, Ellis, Luo, Jingqin, Tao, Yu, Hoog, Jeremy, Laury, Marie L., Summa, Tracy, Hammerschmidt, Trish, Guo, Zhanfang, Frith, Ashley, Weilbaecher, Katherine, Opyrchal, Mateusz, Aft, Rebecca, Clifton, Katherine, Suresh, Rama, Bagegni, Nusayba, Hagemann, Ian S., Iglesia, Michael D., Ma, Cynthia X.

Volltext

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer von Ademuyiwa, Foluso O., Bshara, Wiam, Attwood, Kristopher, Morrison, Carl, Edge, Stephen B., Ambrosone, Christine B., O’Connor, Tracey L., Levine, Ellis G., Miliotto, Anthony, Ritter, Erika, Ritter, Gerd, Gnjatic, Sacha, Odunsi, Kunle

Volltext

Efficacy of Palbociclib Combinations in Hormone Receptor–Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment von Dhakal, Ajay, Matthews, Christina M., Levine, Ellis Glenn, Salerno, Kilian Elizabeth, Zhang, Fan, Takabe, Kazuaki, Early, Amy P., Edge, Stephen B., O'Connor, Tracy, Khoury, Thaer, Young, Jessica S., Opyrchal, Mateusz

Volltext